Figure 3.
Treg and adhesion molecule induction by 2D-MSCs and 3D-MSCs. (A) Enhancement of CD4+ CD25high FOXP3+ Tregs cells by 2D-MSCs. (B) Gating strategy for analysis of CD25hiFOXP3+ population in CD4 cells. (C) Reduction of CD8+CD28− Treg cells in PBMCs co-cultured with 3D-MSCs. (D) Gating strategy for analysis of CD8+CD28− population in CD3+ cells. (E) Levels of IFN-γ and IL-10 in the inflammatory medium produced by PHA-activated PBMCs. (F,G) VCAM-1 and ICAM-1 expression on 2D-MSCs and 3D-MSCs cultured in non-inflammatory conditions. (H,I) VCAM-1 and ICAM-1 expression on 2D-MSCs and 3D-MSCs cultured in inflammatory medium. * p < 0.05; ** p < 0.01; *** p < 0.001, **** p < 0.0001.